The industry size of calcium supplement in Korea is estimated to be US$ 96 million in 2023. The industry is estimated to surpass US$ 279.4 million by 2033, exhibiting 11.3% CAGR. The industry analysis suggests that demand for personal care products and dietary supplements drives the trend of health related supplementation like calcium supplement.
Size, Analysis and Insights of Calcium Supplement Industry in Korea
| Attributes | Details |
|---|---|
| Korea Calcium Supplement Industry Value for 2023 | US$ 96 million |
| Projected Industry Value for 2033 | US$ 279.4 million |
| Value-based CAGR for 2023 to 2033 | 11.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Principal Consultant
The report on the calcium supplement industry in Korea can be divided into two segments: form and end use, with a notable dominance observed in the soft gel form and men end use categories.
The soft gel segment is expected to hold an industry share of 56.1% in 2023. It dominates the industry owing to its advantages, such as being easier to swallow and being ideal for oil- and fat-soluble formulations. The addition of carrageenan in vegetarian and vegan encapsulation enables people with dietary constraints to have more options in their supplement, vitamin, and mineral selections.
| Attributes | Details |
|---|---|
| Form | Soft Gel |
| Industry Share in 2023 | 56.1% |
The men's segment is expected to account for an industry share of 36.4% in 2023 due to the increasing use of supplements by men. The rising health consciousness and gymnasium lifestyle among men are expected to create significant opportunities for calcium supplement sales in Korea.
| Attributes | Details |
|---|---|
| End Use | Men |
| Industry Share in 2023 | 36.4% |
Companies like Dong-A Pharmaceutical Co., Ltd., Youngpoong Pharma Corporation, Kyungdong Pharmaceutical Co., Ltd., and Green Cross Pharma Corporation already have a strong foothold in the industry. Manufacturers are creating strong brand identities through effective marketing strategies to boost customer retention. Manufacturing processes are being improved, and the supply chain is being optimized to enhance capacity and meet increased demand.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Dong-A Pharmaceutical Co., Ltd
Founded in 1945, Dong-A Pharmaceutical Co., Ltd. is one of the leading pharmaceutical companies in South Korea. The company produces a wide range of pharmaceutical products, including calcium supplements. Dong-A Pharmaceutical's calcium supplements are made with high-quality ingredients and have been clinically proven to be effective in increasing bone density and reducing the risk of osteoporosis.
Youngpoong Pharma Corporation
Youngpoong Pharma Corporation is a pharmaceutical company in South Korea. The company was founded in 1973 and produces a wide range of pharmaceutical products, including calcium supplements. Youngpoong Pharma's calcium supplements are made with high-quality ingredients and are clinically proven to be effective in increasing bone density and reducing the risk of osteoporosis.
| Attribute | Details |
|---|---|
| Estimated Industry Size in 2023 | US$ 96 million |
| Projected Industry Size by 2033 | US$ 279.4 million |
| Anticipated CAGR between 2023 to 2033 | 11.3% CAGR |
| Historical Analysis of Demand for Calcium supplement in Korea | 2018 to 2022 |
| Demand Forecast for Calcium supplement in Korea | 2023 to 2033 |
| Report Coverage | Industry Size, Industry Trends, Key Insights for Calcium supplement adoption in Korea, Insights on Global Players and Leading Industry Strategy in Korea, Ecosystem Analysis of Local and Regional. |
| Key Companies Profiled | Dong-A Pharmaceutical Co., Ltd.; Youngpoong Pharma Corporation; Kyungdong Pharmaceutical Co., Ltd.; Green Cross Pharma Corporation; Samyang Holdings Co., Ltd.; First Pharmaceutical Co., Ltd.; JW Pharmaceutical Co., Ltd.; Chunyang Pharmaceutical Co., Ltd.; Hansong Pharmaceutical Co., Ltd.; Ottogi Corporation; GSK; Pfizer; Bayer; Novartis; Abbott; Eisai; Takeda; Astellas; AstraZeneca; Sanofi |
In 2023, the size of the calcium supplement in Korea is estimated to be US$ 96 million.
Increased demand for personal care products and increasing health consciousness are key trends in the calcium supplement industry in Korea.
The calcium supplement industry in Korea is expected to progress at a remarkable CAGR of 11.3% from 2023 to 2033.
By 2033, the industry size of the calcium supplement in Korea is forecasted to reach US$ 279.4 million.
Dong-A Pharmaceutical Co., Ltd., Youngpoong Pharma Corporation, Kyungdong Pharmaceutical Co., Ltd., Green Cross Pharma Corporation are some of the prominent players in the calcium supplement in Korea.
1. Executive Summary
1.1. Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Gummy
5.3.2. Pill
5.3.3. Capsule
5.3.4. Liquid
5.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Product, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Product, 2023 to 2033
6.3.1. Calcium Carbonate
6.3.2. Calcium Gluconate
6.3.3. Calcium Citrate
6.3.4. Calcium Lactate
6.3.5. Calcium Phosphate
6.3.6. Calcium Orotate
6.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Applications
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Applications, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Applications, 2023 to 2033
7.3.1. Adult
7.3.2. Children
7.4. Y-o-Y Growth Trend Analysis By Applications, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Applications, 2023 to 2033
8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2023 to 2033
8.3.1. South Gyeongsang
8.3.2. North Jeolla
8.3.3. South Jeolla
8.3.4. Jeju
8.3.5. Rest of
8.4. Market Attractiveness Analysis By Region
9. South Gyeongsang Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Type
9.2.2. By Product
9.2.3. By Applications
9.3. Market Attractiveness Analysis
9.3.1. By Type
9.3.2. By Product
9.3.3. By Applications
9.4. Key Takeaways
10. North Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Type
10.2.2. By Product
10.2.3. By Applications
10.3. Market Attractiveness Analysis
10.3.1. By Type
10.3.2. By Product
10.3.3. By Applications
10.4. Key Takeaways
11. South Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Type
11.2.2. By Product
11.2.3. By Applications
11.3. Market Attractiveness Analysis
11.3.1. By Type
11.3.2. By Product
11.3.3. By Applications
11.4. Key Takeaways
12. Jeju Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Type
12.2.2. By Product
12.2.3. By Applications
12.3. Market Attractiveness Analysis
12.3.1. By Type
12.3.2. By Product
12.3.3. By Applications
12.4. Key Takeaways
13. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Type
13.2.2. By Product
13.2.3. By Applications
13.3. Market Attractiveness Analysis
13.3.1. By Type
13.3.2. By Product
13.3.3. By Applications
13.4. Key Takeaways
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Type
14.3.3. By Product
14.3.4. By Applications
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Omya
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. Pipelinepharma
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. Pfizer (Caltrate)
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. AandZ Pharmaceutical
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. Amway(Nutrilite)
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
15.1.6. Shanxi Zhendong Pharmaceutical Co., Ltd.
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.6.5.3. Channel Strategy
15.1.7. Nature Made
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.7.5.3. Channel Strategy
15.1.8. By-health Co., Ltd.
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.8.5.2. Product Strategy
15.1.8.5.3. Channel Strategy
15.1.9. Harbin Pharmaceutical Group
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.9.5.2. Product Strategy
15.1.9.5.3. Channel Strategy
15.1.10. Bayer AG
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.10.5.2. Product Strategy
15.1.10.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Food and Beverage Insights
View Reports
Demand and Trend Analysis of Calcium Supplement in Korea
